Ingenuity Systems selects Biodiagnostics as new distributor of IPA in Greece, Turkey and Balkan countries

Ingenuity Systems, the leading provider of information solutions for life science researchers, has selected Biodiagnostics as its new distributor of IPA® in Greece, Turkey and the Balkan countries. IPA is the leading software application to model, analyze, and understand the complex biological and chemical systems at the core of life science research.

"Biodiagnostics is recognized as the premier distributor of life science instruments, reagents, software and services in Greece and the Balkan countries, so we are very pleased with this partnership," said Sean Scott, Senior Vice President, Commercial Operations, Ingenuity Systems. "Biodiagnostics has strong expertise in microarray, cell signaling, and genomics products and services, so IPA is a great complement to Biodiagnostics' existing offerings. Researchers leveraging these platforms request IPA because it can be used for multiple research objectives, in a variety of therapy areas, and it supports multiple data types including gene expression, siRNA, proteomic, metabolomic, and SNP data."

"We are excited that through our partnership with Ingenuity, we are now able to offer IPA, the industry-leading drug discovery and life science research tool," said Hariklia Moshoyiannis, Managing Director, Biodiagnostics. "IPA is popular with researchers because it significantly decreases the time it takes to get from data generation to biological insight, so the net result for Biodiagnostics' customers will be an accelerated publication, or validating results to rapidly move to the next phase of their project."

Source:

Ingenuity Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine